臨床試験を検索：HB-201 intravenous administration at recommended phase II dose and determined schedule.
合計0件
何も見つかりません
このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。
スポンサーと協力者
- Geon Corporation
- INSERM UMR U1075 Comète GIP Cyceron, unicaen, Caen Normandie
- Open Society Institute
- Leqing People's Hospital
- Joseph Blader
- Ministère de la Santé et des Solidarités
- R3 Stem Cell
- Carine Beysen
- Integrated Hospital of Traditional Chinese Medicine, Southern Medical University
- UNITI Consortium
- John Granton
- Sharon Nachman
- Heidelberg University - Coordination Centre for Clinical Trials (KKS) of Heidelberg University
- Charité Berlin, Germany
- Mark Hallett
- Leiden University Medical Center, LUMC, Leiden, The Netherlands
- King Christian X foundation
- Ministry of Health, Singapore
- Shandong Mental Health Center
- Danish Technological Institute
- 全リストを表示
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Burundi
- Contract Research Organizations in Cyprus
- Contract Research Organizations in France
- Contract Research Organizations in Hungary
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Philippines
- Contract Research Organizations in Singapore
- Contract Research Organizations in Suriname
- Contract Research Organizations in Turkmenistan
- Contract Research Organizations in Ukraine
- CRO list by country